The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Exelixis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Results from KEYNOTE-427 cohort B.
 
David F. McDermott
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Bristol-Myers Squibb; Prometheus (Inst)
 
Jae-Lyun Lee
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Pfizer; Sanofi/Aventis
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche/Genentech
 
Marek Ziobro
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
 
Rustem Airatovich Gafanov
No Relationships to Disclose
 
Cristina Suárez
No Relationships to Disclose
 
Frede Donskov
Research Funding - Ipsen; Novartis; Pfizer
 
Frederic Pouliot
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Genzyme; Janssen; Sanofi
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma (I); Bayer; Genzyme; Janssen; Sanofi
 
Boris Y. Alekseev
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Merck; Roche
 
Pawel Wiechno
Honoraria - Astellas Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Astellas Pharma; Ipsen; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer
 
Piotr Tomczak
No Relationships to Disclose
 
Miguel Angel Climent Duran
Honoraria - Bristol-Myers Squibb; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer; Roche
 
Sang Joon Shin
No Relationships to Disclose
 
Rachel Kloss Silverman
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Rodolfo F. Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Charles Schloss
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Glactone Pharma; Iovance Biotherapeutics; Merck; Newlink Genetics/Pharmatech; Novartis; Oncolys BioPharma; Pfizer; Surface Oncology; Werewolf Pharma; X4 Pharma